ArticleeLife2024

Metabolomics identifies and validates serum androstenedione as novel biomarker for diagnosing primary angle closure glaucoma and predicting the visual field progression.

Shengjie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.